Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Synovial Sarcoma”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Early research (Phase 1)Not Yet RecruitingNCT06748872
What this trial is testing

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Who this might be right for
Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more
Medigene AG 55
Early research (Phase 1)Ended earlyNCT03670069
What this trial is testing

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic Sarcoma+15 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT03719430
What this trial is testing

APX005M and Doxorubicin in Advanced Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alexander Z. Wei, MD 27
Early research (Phase 1)Ended earlyNCT03604783
What this trial is testing

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSarcomaEwing Sarcoma+2 more
Sumitomo Pharma America, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650986
What this trial is testing

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Melanoma+47 more
Roswell Park Cancer Institute 15
Early research (Phase 1)Ended earlyNCT05943990
What this trial is testing

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
Adaptimmune 5
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Early research (Phase 1)Looking for participantsNCT07613723
What this trial is testing

Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies

Who this might be right for
Ovarian CancerSquamous Non-Small Cell Lung Cancer (NSCLC)Synovial Sarcomas+1 more
Zelluna Immunotherapy AS 9
Early research (Phase 1)Looking for participantsNCT06083883
What this trial is testing

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Who this might be right for
Synovial SarcomaMyxoid/Round Cell Liposarcoma
M.D. Anderson Cancer Center 44
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Early research (Phase 1)WithdrawnNCT02059850
What this trial is testing

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Adult Synovial SarcomaMyxoid/Round Cell LiposarcomaRecurrent Adult Soft Tissue Sarcoma+2 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00668148
What this trial is testing

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Who this might be right for
Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET)RhabdomyosarcomaLeiomyosarcoma+2 more
Eli Lilly and Company 113
Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Testing effectiveness (Phase 2)Active Not RecruitingNCT05993299
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM, LLC (dba US WorldMeds) 7
Load More Results